Furthermore, consistent with the hypothesis about a role for BVR-A, we previously reported that in PBMC collected from obese and lean individuals, reduced BVR-A levels and activation were associated with increased NAFLD and VAT inflammation [34]. This evidence concerns the gene BLVRA and metabolic dysfunction-associated steatotic liver disease.